Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies
Business Model:
Revenue: $0
Employees: 10,001-1
Address:
City: South San Francisco
State: California
Zip:
Country: United States
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2008 | Series C | 7 | $79M |
Latterell Venture Partners Advanced Technology Ventures Phase4 Ventures Westfield Capital Management U.S. Venture Partners Delphi Ventures The Vertical Group Phase4 Ventures Latterell Venture Partners Advanced Technology Ventures Phase4 Ventures Westfield Capital Management U.S. Venture Partners Delphi Ventures The Vertical Group Phase4 Ventures |
12/2003 | Series A | $18.3M | 6/2006 | Series B | 1 | $45M |
Delphi Ventures Delphi Ventures Delphi Ventures Delphi Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|